CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 16,533 shares (grant or award)
- 4 Grant or award CEO acquired 43,567 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 709 shares at $3.04 ($2,153)
- 4 Planned sale SVP, Chief Financial Officer sold 453 shares at $3.04 ($1,376)
- 4 Planned sale CEO sold 5,124 shares at $3.04 ($15,563)
- S-3 Offering Registration Statement
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP, Chief Financial Officer sold 678 shares at $2.58 ($1,749)
Page 1 of 37 · 731 filings